Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
University of California, Davis Genentech |
---|---|
Information provided by: | University of California, Davis |
ClinicalTrials.gov Identifier: | NCT00371163 |
Spongiotic dermatitis is the histopathologic diagnosis commonly issued by dermatopathologists that encompasses atopic dermatitis, contact dermatitis, and other forms of eczematous dermatitis.
The information obtained will assist in development of diagnostic methods for differentiation of the types of spongiotic dermatitis. This study also has the potential to lead to the dissection of pathologic pathways involved in these diseases and development of novel therapeutic agents.
Condition | Intervention | Phase |
---|---|---|
Atopic Dermatitis Psoriasis Contact Dermatitis |
Procedure: microarray analyses. |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Diagnostic, Non-Randomized, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Molecular and Cellular Characterization of Spongiotic Dermatitis |
Estimated Enrollment: | 50 |
Study Start Date: | September 2006 |
Estimated Study Completion Date: | December 2008 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Spongiotic dermatitis is the histopathologic diagnosis commonly issued by dermatopathologists that encompasses atopic dermatitis, contact dermatitis, and other forms of eczematous dermatitis. Atopic dermatitis is a chronic, relapsing inflammatory disease characterized by pruritic, scaly, red, eczematous skin lesions, and a personal or family history of atopy. Patients affected by atopic dermatitis experience significant morbidity from extreme pruritus, recurrent cutaneous infections, and extensive and/or disfiguring skin lesions. Allergic contact dermatitis typically manifests as pruritus and vesicular or eczematous lesions associated with direct exposure to environmental haptenic allergens.
The specific aims of this research are:
The information obtained will assist in development of diagnostic methods for differentiation of the types of spongiotic dermatitis. This study also has the potential to lead to the dissection of pathologic pathways involved in these diseases and development of novel therapeutic agents.
Ages Eligible for Study: | 18 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Atopic Dermatitis: Subjects will be identified based on the Hanifin criteria of atopic dermatitis.
Subjects will be adults with a history of atopic dermatitis since childhood, who continue to have symptoms and signs of atopic dermatitis. They must have active lesions and should not be on systemic therapy.
Subjects will be asked to discontinue topical medications at least to parts of the skin where biopsies will be taken, one week prior to biopsy.
-
Exclusion Criteria:
Contact: Fu- Tong Liu, M.D., PhD. | 916-734-6795 | fliu@ucdavis.edu |
Contact: Jennifer Nava, CRC | 916-734-1438 | jennifer.nava@ucdmc.ucdavis.edu |
United States, California | |
UC Davis Department of Dermatology | Recruiting |
Sacramento, California, United States, 95816 | |
Principal Investigator: Fu Tong Liu, M.D., PhD. |
Principal Investigator: | Fu -Tong Liu, M.D., PhD. | Professor and Chair of UCDavis Dermatology |
Responsible Party: | University of California Davis ( Fu-Tong Liu ) |
Study ID Numbers: | 200614530-1 |
Study First Received: | August 30, 2006 |
Last Updated: | August 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00371163 History of Changes |
Health Authority: | United States: Institutional Review Board |
Identification of genes by microarray analyses. |
Hypersensitivity Dermatitis, Atopic Genetic Diseases, Inborn Skin Diseases Psoriasis Hypersensitivity, Immediate |
Skin Diseases, Eczematous Skin Diseases, Papulosquamous Skin Diseases, Genetic Dermatitis, Contact Dermatitis |
Hypersensitivity Dermatitis, Atopic Immune System Diseases Genetic Diseases, Inborn Skin Diseases Psoriasis |
Hypersensitivity, Immediate Skin Diseases, Eczematous Skin Diseases, Papulosquamous Skin Diseases, Genetic Dermatitis, Contact Dermatitis |